![]() |
Name |
trisorbicillinone E
|
Molecular Formula | C43H54O11 | |
IUPAC Name* |
3,10-dihydroxy-6-[hydroxy-[6-hydroxy-3-(1-hydroxyhex-4-enylidene)-4,6-dimethyl-5-methylidene-8-oxo-7-prop-1-enyl-2-bicyclo[2.2.2]octanyl]methylidene]-13-(1-hydroxyhex-4-enylidene)-1,4,8,11-tetramethyl-2,9-dioxapentacyclo[8.4.0.03,8.04,14.07,11]tetradecane-5,12-dione
|
|
SMILES |
C=C1C(C)(O)C2C(=C(O)CCC=CC)C(=O)C1(C)C(C=CC)C2C(O)=C1C(=O)C2(C)C3C(=C(O)CCC=CC)C(=O)C4(C)C1C1(C)OC4(O)C3(C)OC12O
|
|
InChI |
InChI=1S/C43H54O11/c1-11-14-16-19-23(44)26-29-25(22(18-13-3)36(5,33(26)47)21(4)39(29,8)50)30(46)28-32-38(7)34(48)27(24(45)20-17-15-12-2)31-37(6,35(28)49)42(51)41(32,10)54-43(38,52)40(31,9)53-42/h11-15,18,22,25,29,31-32,44-46,50-52H,4,16-17,19-20H2,1-3,5-10H3/b14-11+,15-12+,18-13+,26-23-,27-24-,30-28-/t22?,25-,29?,31?,32+,36-,37+,38?,39+,40-,41-,42+,43+/m0/s1
|
|
InChIKey |
RCVDAJYYIJTDGQ-FZRMGVSSSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 746.89 | ALogp: | 5.8 |
HBD: | 6 | HBA: | 11 |
Rotatable Bonds: | 8 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 191.0 | Aromatic Rings: | 7 |
Heavy Atoms: | 54 | QED Weighted: | 0.074 |
Caco-2 Permeability: | -5.427 | MDCK Permeability: | 0.00002110 |
Pgp-inhibitor: | 0.784 | Pgp-substrate: | 0.213 |
Human Intestinal Absorption (HIA): | 0.238 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0.006 |
Blood-Brain-Barrier Penetration (BBB): | 0.059 | Plasma Protein Binding (PPB): | 69.07% |
Volume Distribution (VD): | 0.66 | Fu: | 11.14% |
CYP1A2-inhibitor: | 0 | CYP1A2-substrate: | 0.981 |
CYP2C19-inhibitor: | 0.01 | CYP2C19-substrate: | 0.841 |
CYP2C9-inhibitor: | 0.005 | CYP2C9-substrate: | 0.005 |
CYP2D6-inhibitor: | 0.001 | CYP2D6-substrate: | 0.025 |
CYP3A4-inhibitor: | 0.941 | CYP3A4-substrate: | 0.948 |
Clearance (CL): | 8.865 | Half-life (T1/2): | 0.008 |
hERG Blockers: | 0 | Human Hepatotoxicity (H-HT): | 0.069 |
Drug-inuced Liver Injury (DILI): | 0.935 | AMES Toxicity: | 0.014 |
Rat Oral Acute Toxicity: | 1 | Maximum Recommended Daily Dose: | 0.013 |
Skin Sensitization: | 0.002 | Carcinogencity: | 0.856 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.022 |
Respiratory Toxicity: | 0.54 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003762 | ![]() |
0.457 | D0H2MO | ![]() |
0.202 | ||
ENC004472 | ![]() |
0.448 | D0KR9U | ![]() |
0.177 | ||
ENC003187 | ![]() |
0.398 | D0E4SI | ![]() |
0.175 | ||
ENC002133 | ![]() |
0.364 | D0J2NK | ![]() |
0.174 | ||
ENC003709 | ![]() |
0.354 | D04VEJ | ![]() |
0.173 | ||
ENC002144 | ![]() |
0.348 | D02GAC | ![]() |
0.163 | ||
ENC004086 | ![]() |
0.337 | D0FW2A | ![]() |
0.162 | ||
ENC003579 | ![]() |
0.330 | D0WY9N | ![]() |
0.161 | ||
ENC005987 | ![]() |
0.313 | D0E9KA | ![]() |
0.160 | ||
ENC004085 | ![]() |
0.293 | D04JMQ | ![]() |
0.158 |